Frequencies for first 10,000 rows of indi_pt variable in indi2010q1 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABDOMINAL DISCOMFORT | 4 0.04 0.04 ABDOMINAL DISTENSION | 2 0.02 0.06 ABDOMINAL HERNIA | 1 0.01 0.07 ABDOMINAL HERNIA REPAIR | 1 0.01 0.08 ABDOMINAL OPERATION | 1 0.01 0.09 ABDOMINAL PAIN | 11 0.11 0.20 ABDOMINAL PAIN UPPER | 3 0.03 0.23 ABNORMAL BEHAVIOUR | 1 0.01 0.24 ABORTION INDUCED | 1 0.01 0.25 ACARODERMATITIS | 5 0.05 0.30 ACCIDENTAL EXPOSURE | 7 0.07 0.37 ACNE | 13 0.13 0.50 ACQUIRED IMMUNODEFICIENCY SYNDROME | 9 0.09 0.59 ACROMEGALY | 7 0.07 0.66 ACTH-PRODUCING PITUITARY TUMOUR | 1 0.01 0.67 ACUTE CORONARY SYNDROME | 8 0.08 0.75 ACUTE LYMPHOCYTIC LEUKAEMIA | 49 0.49 1.24 ACUTE MYELOID LEUKAEMIA | 14 0.14 1.38 ACUTE MYELOID LEUKAEMIA (IN REMISSION) | 1 0.01 1.39 ACUTE MYELOID LEUKAEMIA RECURRENT | 5 0.05 1.44 ACUTE MYOCARDIAL INFARCTION | 2 0.02 1.46 ACUTE PROMYELOCYTIC LEUKAEMIA | 2 0.02 1.48 ADENOCARCINOMA | 2 0.02 1.50 ADJUVANT THERAPY | 2 0.02 1.52 ADRENAL CARCINOMA | 1 0.01 1.53 ADRENAL GLAND CANCER METASTATIC | 2 0.02 1.55 ADRENOCORTICAL CARCINOMA | 2 0.02 1.57 ADVERSE DRUG REACTION | 4 0.04 1.61 AFFECT LABILITY | 2 0.02 1.63 AFFECTIVE DISORDER | 10 0.10 1.73 AGGRESSION | 2 0.02 1.75 AGITATION | 5 0.05 1.80 AGRANULOCYTOSIS | 1 0.01 1.81 ALCOHOL WITHDRAWAL SYNDROME | 1 0.01 1.82 ALCOHOLIC | 1 0.01 1.83 ALCOHOLISM | 1 0.01 1.84 ALLERGENIC DESENSITISATION PROCEDURE | 1 0.01 1.85 ALLERGY PROPHYLAXIS | 4 0.04 1.89 ALLERGY TEST | 1 0.01 1.90 ALLERGY TO ANIMAL | 1 0.01 1.91 ALLERGY TO ARTHROPOD STING | 1 0.01 1.92 ALLERGY TO VENOM | 1 0.01 1.93 ALOPECIA | 6 0.06 1.99 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 2.00 ANAEMIA | 18 0.18 2.18 ANAEMIA OF MALIGNANT DISEASE | 1 0.01 2.19 ANAESTHESIA | 13 0.13 2.32 ANAESTHESIA REVERSAL | 2 0.02 2.34 ANAESTHETIC PREMEDICATION | 2 0.02 2.36 ANAL CANCER | 4 0.04 2.40 ANAL FISSURE | 1 0.01 2.41 ANAL FISTULA | 2 0.02 2.43 ANALGESIC THERAPY | 9 0.09 2.52 ANAPHYLACTIC REACTION | 2 0.02 2.54 ANDROGENETIC ALOPECIA | 1 0.01 2.55 ANGINA PECTORIS | 17 0.17 2.72 ANGINA UNSTABLE | 4 0.04 2.76 ANGIOGRAM | 7 0.07 2.83 ANGIOPATHY | 1 0.01 2.84 ANIMAL BITE | 1 0.01 2.85 ANKYLOSING SPONDYLITIS | 19 0.19 3.04 ANOGENITAL WARTS | 1 0.01 3.05 ANORECTAL VARICES | 1 0.01 3.06 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 3 0.03 3.09 ANTIBIOTIC PROPHYLAXIS | 7 0.07 3.16 ANTIBIOTIC THERAPY | 1 0.01 3.17 ANTICOAGULANT THERAPY | 14 0.14 3.31 ANTIDEPRESSANT THERAPY | 3 0.03 3.34 ANTIEMETIC SUPPORTIVE CARE | 3 0.03 3.37 ANTIFUNGAL PROPHYLAXIS | 8 0.08 3.45 ANTIINFLAMMATORY THERAPY | 1 0.01 3.46 ANTIOXIDANT THERAPY | 1 0.01 3.47 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 3.48 ANTIPLATELET THERAPY | 4 0.04 3.52 ANTIRETROVIRAL THERAPY | 28 0.28 3.80 ANTIVIRAL PROPHYLAXIS | 5 0.05 3.85 ANTIVIRAL TREATMENT | 20 0.20 4.05 ANXIETY | 70 0.70 4.75 ANXIETY DISORDER | 2 0.02 4.77 AORTIC ANEURYSM REPAIR | 1 0.01 4.78 AORTIC VALVE INCOMPETENCE | 1 0.01 4.79 AORTIC VALVE REPLACEMENT | 3 0.03 4.82 APATHY | 3 0.03 4.85 APHTHOUS STOMATITIS | 2 0.02 4.87 APLASTIC ANAEMIA | 4 0.04 4.91 ARRHYTHMIA | 10 0.10 5.01 ARTERIAL DISORDER | 1 0.01 5.02 ARTERIAL OCCLUSIVE DISEASE | 1 0.01 5.03 ARTERIAL THROMBOSIS LIMB | 1 0.01 5.04 ARTERIOGRAM CORONARY | 1 0.01 5.05 ARTERIOSCLEROSIS | 2 0.02 5.07 ARTERIOSCLEROSIS OBLITERANS | 4 0.04 5.11 ARTERITIS OBLITERANS | 1 0.01 5.12 ARTHRALGIA | 33 0.33 5.45 ARTHRITIS | 49 0.49 5.94 ARTHRITIS BACTERIAL | 1 0.01 5.95 ARTHROGRAM | 1 0.01 5.96 ARTHROPATHY | 2 0.02 5.98 ARTHROPOD BITE | 3 0.03 6.01 ASCITES | 3 0.03 6.04 ASPERGILLOSIS | 4 0.04 6.08 ASTHENIA | 2 0.02 6.10 ASTHMA | 132 1.32 7.42 ATRIAL FIBRILLATION | 61 0.61 8.03 ATRIAL FLUTTER | 3 0.03 8.06 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 23 0.23 8.29 AUTOIMMUNE HEPATITIS | 1 0.01 8.30 AUTOIMMUNE THYROIDITIS | 1 0.01 8.31 AUTONOMIC DYSREFLEXIA | 1 0.01 8.32 B-CELL LYMPHOMA | 23 0.23 8.55 BACK DISORDER | 2 0.02 8.57 BACK PAIN | 58 0.58 9.15 BACTERIAL DISEASE CARRIER | 1 0.01 9.16 BACTERIAL INFECTION | 16 0.16 9.32 BALANITIS | 1 0.01 9.33 BALANOPOSTHITIS | 1 0.01 9.34 BALLISMUS | 1 0.01 9.35 BEHCET'S SYNDROME | 4 0.04 9.39 BENIGN PROSTATIC HYPERPLASIA | 24 0.24 9.63 BILIARY CIRRHOSIS PRIMARY | 1 0.01 9.64 BIPOLAR DISORDER | 37 0.37 10.01 BIPOLAR I DISORDER | 8 0.08 10.09 BIPOLAR II DISORDER | 1 0.01 10.10 BLADDER CANCER | 7 0.07 10.17 BLADDER DISORDER | 2 0.02 10.19 BLADDER SPASM | 1 0.01 10.20 BLADDER TRANSITIONAL CELL CARCINOMA | 1 0.01 10.21 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA | 1 0.01 10.22 BLEPHAROSPASM | 1 0.01 10.23 BLOOD CHOLESTEROL | 19 0.19 10.42 BLOOD CHOLESTEROL ABNORMAL | 4 0.04 10.46 BLOOD CHOLESTEROL INCREASED | 74 0.74 11.20 BLOOD GLUCOSE | 2 0.02 11.22 BLOOD GLUCOSE ABNORMAL | 1 0.01 11.23 BLOOD GLUCOSE INCREASED | 4 0.04 11.27 BLOOD GROWTH HORMONE | 1 0.01 11.28 BLOOD POTASSIUM | 2 0.02 11.30 BLOOD PRESSURE | 26 0.26 11.56 BLOOD PRESSURE ABNORMAL | 1 0.01 11.57 BLOOD PRESSURE DECREASED | 1 0.01 11.58 BLOOD PRESSURE INCREASED | 9 0.09 11.67 BLOOD PRESSURE MANAGEMENT | 1 0.01 11.68 BLOOD PRODUCT TRANSFUSION DEPENDENT | 1 0.01 11.69 BLOOD TRIGLYCERIDES | 1 0.01 11.70 BLOOD TRIGLYCERIDES INCREASED | 4 0.04 11.74 BODY TEMPERATURE INCREASED | 4 0.04 11.78 BONE DENSITY ABNORMAL | 1 0.01 11.79 BONE DENSITY DECREASED | 2 0.02 11.81 BONE DISORDER | 2 0.02 11.83 BONE LESION | 2 0.02 11.85 BONE MARROW FAILURE | 6 0.06 11.91 BONE MARROW TRANSPLANT | 1 0.01 11.92 BONE PAIN | 4 0.04 11.96 BOWEL MOVEMENT IRREGULARITY | 3 0.03 11.99 BRADYCARDIA | 1 0.01 12.00 BREAKTHROUGH PAIN | 11 0.11 12.11 BREAST CANCER | 119 1.19 13.30 BREAST CANCER METASTATIC | 30 0.30 13.60 BREAST CANCER RECURRENT | 10 0.10 13.70 BREAST LUMP REMOVAL | 1 0.01 13.71 BRONCHIAL DISORDER | 2 0.02 13.73 BRONCHITIS | 17 0.17 13.90 BRONCHITIS BACTERIAL | 1 0.01 13.91 BRONCHITIS CHRONIC | 3 0.03 13.94 BRONCHOPNEUMONIA | 3 0.03 13.97 BRONCHOPULMONARY ASPERGILLOSIS | 2 0.02 13.99 BURKITT'S LYMPHOMA | 20 0.20 14.19 BURSITIS | 1 0.01 14.20 CACHEXIA | 2 0.02 14.22 CALCULUS URETERIC | 1 0.01 14.23 CAMPYLOBACTER GASTROENTERITIS | 1 0.01 14.24 CANCER PAIN | 9 0.09 14.33 CARCINOID SYNDROME | 2 0.02 14.35 CARCINOID TUMOUR | 14 0.14 14.49 CARDIAC DISORDER | 37 0.37 14.86 CARDIAC FAILURE | 16 0.16 15.02 CARDIAC FAILURE ACUTE | 1 0.01 15.03 CARDIAC FAILURE CONGESTIVE | 3 0.03 15.06 CARDIAC OPERATION | 5 0.05 15.11 CARDIAC PACEMAKER INSERTION | 1 0.01 15.12 CARDIAC VALVE DISEASE | 1 0.01 15.13 CARDIOVASCULAR DISORDER | 3 0.03 15.16 CARDIOVASCULAR EVENT PROPHYLAXIS | 8 0.08 15.24 CAROTID ARTERY DISSECTION | 1 0.01 15.25 CAROTID ARTERY STENOSIS | 3 0.03 15.28 CATARACT | 5 0.05 15.33 CATARACT OPERATION | 2 0.02 15.35 CATHETERISATION CARDIAC | 2 0.02 15.37 CELLULITIS | 2 0.02 15.39 CEREBRAL INFARCTION | 6 0.06 15.45 CEREBRAL VENOUS THROMBOSIS | 2 0.02 15.47 CEREBROVASCULAR ACCIDENT | 3 0.03 15.50 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 12 0.12 15.62 CERVIX CARCINOMA | 1 0.01 15.63 CHEILITIS | 1 0.01 15.64 CHELATION THERAPY | 1 0.01 15.65 CHEMOTHERAPY | 14 0.14 15.79 CHEST DISCOMFORT | 11 0.11 15.90 CHEST PAIN | 5 0.05 15.95 CHOLESTASIS | 1 0.01 15.96 CHOROID MELANOMA | 1 0.01 15.97 CHRONIC LYMPHOCYTIC LEUKAEMIA | 10 0.10 16.07 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT | 2 0.02 16.09 CHRONIC MYELOID LEUKAEMIA | 44 0.44 16.53 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 125 1.25 17.78 CHRONIC SINUSITIS | 1 0.01 17.79 CIRRHOSIS ALCOHOLIC | 1 0.01 17.80 CLUSTER HEADACHE | 1 0.01 17.81 COAGULOPATHY | 2 0.02 17.83 COLECTOMY | 5 0.05 17.88 COLITIS | 1 0.01 17.89 COLITIS ULCERATIVE | 33 0.33 18.22 COLON CANCER | 23 0.23 18.45 COLON CANCER METASTATIC | 3 0.03 18.48 COLON CANCER STAGE III | 1 0.01 18.49 COLORECTAL CANCER | 19 0.19 18.68 COLORECTAL CANCER METASTATIC | 5 0.05 18.73 COLOSTOMY | 1 0.01 18.74 COMA | 1 0.01 18.75 COMBINED IMMUNODEFICIENCY | 1 0.01 18.76 COMPLEX REGIONAL PAIN SYNDROME | 2 0.02 18.78 COMPUTERISED TOMOGRAM | 7 0.07 18.85 COMPUTERISED TOMOGRAM ABDOMEN | 6 0.06 18.91 COMPUTERISED TOMOGRAM THORAX | 2 0.02 18.93 CONJUNCTIVITIS | 1 0.01 18.94 CONNECTIVE TISSUE DISORDER | 1 0.01 18.95 CONSTIPATION | 47 0.47 19.42 CONSTIPATION PROPHYLAXIS | 5 0.05 19.47 CONTRACEPTION | 117 1.17 20.64 CONVULSION | 30 0.30 20.94 CONVULSION PROPHYLAXIS | 1 0.01 20.95 COR PULMONALE CHRONIC | 1 0.01 20.96 CORD BLOOD TRANSPLANT THERAPY | 2 0.02 20.98 CORNEAL TRANSPLANT | 1 0.01 20.99 CORONARY ARTERIAL STENT INSERTION | 3 0.03 21.02 CORONARY ARTERY DISEASE | 11 0.11 21.13 COUGH | 17 0.17 21.30 CROHN'S DISEASE | 81 0.81 22.11 CUTANEOUS SARCOIDOSIS | 1 0.01 22.12 CYSTIC FIBROSIS | 8 0.08 22.20 CYSTITIS | 3 0.03 22.23 CYTOMEGALOVIRUS INFECTION | 2 0.02 22.25 CYTOREDUCTIVE SURGERY | 1 0.01 22.26 DECREASED APPETITE | 1 0.01 22.27 DEEP VEIN THROMBOSIS | 13 0.13 22.40 DELIRIUM | 3 0.03 22.43 DELUSION | 2 0.02 22.45 DEMENTIA | 3 0.03 22.48 DEMENTIA ALZHEIMER'S TYPE | 11 0.11 22.59 DEMENTIA OF THE ALZHEIMER'S TYPE, UNC.. | 7 0.07 22.66 DEMENTIA WITH LEWY BODIES | 3 0.03 22.69 DEMYELINATION | 1 0.01 22.70 DENTAL CARE | 2 0.02 22.72 DENTAL DISORDER PROPHYLAXIS | 4 0.04 22.76 DEPRESSED MOOD | 3 0.03 22.79 DEPRESSION | 177 1.77 24.56 DERMATITIS ATOPIC | 2 0.02 24.58 DEVICE RELATED INFECTION | 1 0.01 24.59 DIABETES INSIPIDUS | 1 0.01 24.60 DIABETES MELLITUS | 184 1.84 26.44 DIABETES MELLITUS INADEQUATE CONTROL | 1 0.01 26.45 DIABETIC NEPHROPATHY | 3 0.03 26.48 DIABETIC NEUROPATHY | 2 0.02 26.50 DIABETIC RETINAL OEDEMA | 6 0.06 26.56 DIAGNOSTIC PROCEDURE | 7 0.07 26.63 DIALYSIS | 6 0.06 26.69 DIARRHOEA | 11 0.11 26.80 DIFFUSE LARGE B-CELL LYMPHOMA | 25 0.25 27.05 DIURETIC THERAPY | 3 0.03 27.08 DIVERTICULITIS | 1 0.01 27.09 DIZZINESS | 6 0.06 27.15 DRESSLER'S SYNDROME | 4 0.04 27.19 DRUG ABUSE | 3 0.03 27.22 DRUG DEPENDENCE | 2 0.02 27.24 DRUG EXPOSURE DURING PREGNANCY | 48 0.48 27.72 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 2 0.02 27.74 DRUG THERAPY | 1 0.01 27.75 DRUG TOXICITY | 1 0.01 27.76 DRUG USE FOR UNKNOWN INDICATION | 1,895 18.95 46.71 DRY MOUTH | 2 0.02 46.73 DUCHENNE MUSCULAR DYSTROPHY | 3 0.03 46.76 DYSLIPIDAEMIA | 9 0.09 46.85 DYSMENORRHOEA | 4 0.04 46.89 DYSPEPSIA | 23 0.23 47.12 DYSPHAGIA | 1 0.01 47.13 DYSPHONIA | 1 0.01 47.14 DYSPNOEA | 13 0.13 47.27 DYSURIA | 5 0.05 47.32 EAR INFECTION | 1 0.01 47.33 EAR PRURITUS | 1 0.01 47.34 ECTHYMA | 2 0.02 47.36 ECZEMA | 2 0.02 47.38 ELECTROCARDIOGRAM QT PROLONGED | 1 0.01 47.39 ELECTROLYTE IMBALANCE | 1 0.01 47.40 ELECTROLYTE SUBSTITUTION THERAPY | 2 0.02 47.42 EMPHYSEMA | 21 0.21 47.63 ENCEPHALITIS HERPES | 2 0.02 47.65 ENDARTERECTOMY | 1 0.01 47.66 ENDOMETRIAL CANCER | 2 0.02 47.68 ENDOMETRIOSIS | 1 0.01 47.69 ENDOTRACHEAL INTUBATION | 2 0.02 47.71 ENTERITIS INFECTIOUS | 1 0.01 47.72 ENZYME SUPPLEMENTATION | 1 0.01 47.73 EPILEPSY | 67 0.67 48.40 EPISTAXIS | 1 0.01 48.41 ERECTILE DYSFUNCTION | 11 0.11 48.52 ERYSIPELAS | 5 0.05 48.57 ESSENTIAL THROMBOCYTHAEMIA | 1 0.01 48.58 EX-TOBACCO USER | 3 0.03 48.61 EXTRANODAL MARGINAL ZONE B-CELL LYMPH.. | 4 0.04 48.65 EYE DISORDER | 1 0.01 48.66 FACE OEDEMA | 2 0.02 48.68 FACTOR VIII DEFICIENCY | 6 0.06 48.74 FATIGUE | 3 0.03 48.77 FEBRILE BONE MARROW APLASIA | 1 0.01 48.78 FIBROMYALGIA | 15 0.15 48.93 FLANK PAIN | 1 0.01 48.94 FLATULENCE | 2 0.02 48.96 FLUID OVERLOAD | 2 0.02 48.98 FLUID REPLACEMENT | 1 0.01 48.99 FLUID RETENTION | 2 0.02 49.01 FOLATE DEFICIENCY | 1 0.01 49.02 FUNDOSCOPY | 1 0.01 49.03 FUNGAL INFECTION | 4 0.04 49.07 FUNGAL SKIN INFECTION | 1 0.01 49.08 FUSARIUM INFECTION | 1 0.01 49.09 GALLBLADDER CANCER METASTATIC | 3 0.03 49.12 GASTRIC CANCER | 47 0.47 49.59 GASTRIC DISORDER | 3 0.03 49.62 GASTRIC MUCOSAL HYPERTROPHY | 1 0.01 49.63 GASTRIC MUCOSAL LESION | 1 0.01 49.64 GASTRIC ULCER | 6 0.06 49.70 GASTRIN SECRETION DISORDER | 1 0.01 49.71 GASTRITIS | 15 0.15 49.86 GASTRITIS PROPHYLAXIS | 10 0.10 49.96 GASTROINTESTINAL DISORDER | 4 0.04 50.00 GASTROINTESTINAL DISORDER THERAPY | 1 0.01 50.01 GASTROINTESTINAL HAEMORRHAGE | 3 0.03 50.04 GASTROINTESTINAL MOTILITY DISORDER | 1 0.01 50.05 GASTROINTESTINAL STROMAL TUMOUR | 14 0.14 50.19 GASTROOESOPHAGEAL CANCER | 3 0.03 50.22 GASTROOESOPHAGEAL REFLUX DISEASE | 44 0.44 50.66 GENERAL ANAESTHESIA | 4 0.04 50.70 GENERALISED ANXIETY DISORDER | 4 0.04 50.74 GENITAL HERPES | 1 0.01 50.75 GESTATIONAL DIABETES | 7 0.07 50.82 GINGIVAL SWELLING | 1 0.01 50.83 GLAUCOMA | 21 0.21 51.04 GLIOBLASTOMA | 5 0.05 51.09 GLIOBLASTOMA MULTIFORME | 6 0.06 51.15 GLUCOSE TOLERANCE IMPAIRED | 1 0.01 51.16 GOITRE | 1 0.01 51.17 GOUT | 19 0.19 51.36 GOUTY ARTHRITIS | 7 0.07 51.43 GOUTY TOPHUS | 3 0.03 51.46 GRAFT VERSUS HOST DISEASE | 8 0.08 51.54 GRAND MAL CONVULSION | 2 0.02 51.56 GROWTH HORMONE DEFICIENCY | 6 0.06 51.62 H1N1 INFLUENZA | 16 0.16 51.78 HAEMOCHROMATOSIS | 1 0.01 51.79 HAEMOGLOBIN DECREASED | 1 0.01 51.80 HAEMOPHILIA | 3 0.03 51.83 HAEMORRHAGE PROPHYLAXIS | 1 0.01 51.84 HAEMORRHAGE URINARY TRACT | 1 0.01 51.85 HALLUCINATION | 1 0.01 51.86 HEAD AND NECK CANCER | 8 0.08 51.94 HEAD INJURY | 1 0.01 51.95 HEADACHE | 16 0.16 52.11 HEART INJURY | 1 0.01 52.12 HEART RATE | 2 0.02 52.14 HEART RATE INCREASED | 2 0.02 52.16 HEART RATE IRREGULAR | 5 0.05 52.21 HEART TRANSPLANT | 13 0.13 52.34 HEART VALVE REPLACEMENT | 3 0.03 52.37 HELICOBACTER GASTRITIS | 3 0.03 52.40 HEMIPARESIS | 1 0.01 52.41 HEPARIN NEUTRALISATION THERAPY | 1 0.01 52.42 HEPARIN-INDUCED THROMBOCYTOPENIA | 3 0.03 52.45 HEPATIC CIRRHOSIS | 4 0.04 52.49 HEPATIC ENCEPHALOPATHY | 1 0.01 52.50 HEPATIC FUNCTION ABNORMAL | 1 0.01 52.51 HEPATIC NEOPLASM MALIGNANT | 34 0.34 52.85 HEPATIC NEOPLASM MALIGNANT NON-RESECT.. | 1 0.01 52.86 HEPATIC NEOPLASM MALIGNANT RECURRENT | 2 0.02 52.88 HEPATITIS B | 5 0.05 52.93 HEPATITIS C | 41 0.41 53.34 HEPATOBLASTOMA | 3 0.03 53.37 HERNIA PAIN | 1 0.01 53.38 HERPES OPHTHALMIC | 2 0.02 53.40 HERPES SIMPLEX | 2 0.02 53.42 HERPES VIRUS INFECTION | 2 0.02 53.44 HERPES ZOSTER | 8 0.08 53.52 HIATUS HERNIA | 3 0.03 53.55 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 53.56 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 53.57 HIP ARTHROPLASTY | 1 0.01 53.58 HIP SURGERY | 1 0.01 53.59 HISTOPLASMOSIS DISSEMINATED | 1 0.01 53.60 HIV INFECTION | 181 1.81 55.41 HIV TEST POSITIVE | 4 0.04 55.45 HODGKIN'S DISEASE | 17 0.17 55.62 HORMONE REPLACEMENT THERAPY | 23 0.23 55.85 HORMONE THERAPY | 1 0.01 55.86 HOT FLUSH | 4 0.04 55.90 HYDROCHOLECYSTIS | 7 0.07 55.97 HYPERCALCAEMIA | 3 0.03 56.00 HYPERCHOLESTEROLAEMIA | 36 0.36 56.36 HYPEREOSINOPHILIC SYNDROME | 1 0.01 56.37 HYPERGLYCAEMIA | 3 0.03 56.40 HYPERHIDROSIS | 1 0.01 56.41 HYPERKALAEMIA | 2 0.02 56.43 HYPERLIPIDAEMIA | 40 0.40 56.83 HYPERPARATHYROIDISM SECONDARY | 2 0.02 56.85 HYPERPHOSPHATAEMIA | 2 0.02 56.87 HYPERSENSITIVITY | 13 0.13 57.00 HYPERTENSION | 354 3.54 60.54 HYPERTHYROIDISM | 5 0.05 60.59 HYPERTONIC BLADDER | 3 0.03 60.62 HYPERTRIGLYCERIDAEMIA | 1 0.01 60.63 HYPERURICAEMIA | 5 0.05 60.68 HYPNOTHERAPY | 1 0.01 60.69 HYPOALBUMINAEMIA | 2 0.02 60.71 HYPOCALCAEMIA | 1 0.01 60.72 HYPOGAMMAGLOBULINAEMIA | 1 0.01 60.73 HYPOGLYCAEMIA | 2 0.02 60.75 HYPOKALAEMIA | 3 0.03 60.78 HYPOPHYSECTOMY | 2 0.02 60.80 HYPOPITUITARISM | 2 0.02 60.82 HYPOTENSION | 4 0.04 60.86 HYPOTHYROIDISM | 39 0.39 61.25 HYPOTONIA | 1 0.01 61.26 HYSTERECTOMY | 1 0.01 61.27 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 20 0.20 61.47 IGA NEPHROPATHY | 1 0.01 61.48 ILL-DEFINED DISORDER | 2 0.02 61.50 IMAGING PROCEDURE | 1 0.01 61.51 IMMUNISATION | 4 0.04 61.55 IMMUNODEFICIENCY COMMON VARIABLE | 3 0.03 61.58 IMMUNOSUPPRESSANT DRUG THERAPY | 4 0.04 61.62 IMMUNOSUPPRESSION | 10 0.10 61.72 IMPULSE-CONTROL DISORDER | 1 0.01 61.73 INCREASED UPPER AIRWAY SECRETION | 1 0.01 61.74 INDUCTION OF ANAESTHESIA | 13 0.13 61.87 INFARCTION | 1 0.01 61.88 INFECTION | 19 0.19 62.07 INFECTION PROPHYLAXIS | 15 0.15 62.22 INFLAMMATION | 1 0.01 62.23 INFLUENZA | 34 0.34 62.57 INFLUENZA IMMUNISATION | 3 0.03 62.60 INFLUENZA LIKE ILLNESS | 1 0.01 62.61 INGROWING NAIL | 1 0.01 62.62 INJURY | 1 0.01 62.63 INSOMNIA | 49 0.49 63.12 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 3 0.03 63.15 INTENTIONAL OVERDOSE | 1 0.01 63.16 INTERSTITIAL LUNG DISEASE | 2 0.02 63.18 INTERVERTEBRAL DISC COMPRESSION | 2 0.02 63.20 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 63.21 INTERVERTEBRAL DISC PROTRUSION | 1 0.01 63.22 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 63.23 INTESTINAL STOMA | 1 0.01 63.24 INTRA-UTERINE CONTRACEPTIVE DEVICE | 1 0.01 63.25 INTRACRANIAL PRESSURE INCREASED | 1 0.01 63.26 INTRAOCULAR PRESSURE TEST | 1 0.01 63.27 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 63.28 IRON DEFICIENCY | 1 0.01 63.29 IRON DEFICIENCY ANAEMIA | 3 0.03 63.32 IRON METABOLISM DISORDER | 4 0.04 63.36 IRON OVERLOAD | 20 0.20 63.56 IRRITABILITY | 5 0.05 63.61 IRRITABLE BOWEL SYNDROME | 1 0.01 63.62 ISCHAEMIA | 1 0.01 63.63 JOINT INJURY | 2 0.02 63.65 JOINT SPRAIN | 1 0.01 63.66 JOINT STIFFNESS | 1 0.01 63.67 JUVENILE ARTHRITIS | 4 0.04 63.71 KAPOSI'S SARCOMA | 1 0.01 63.72 KERATOCONUS | 1 0.01 63.73 KERATOSIS FOLLICULAR | 2 0.02 63.75 KIDNEY INFECTION | 2 0.02 63.77 LACRIMATION DECREASED | 2 0.02 63.79 LARGE INTESTINE CARCINOMA | 2 0.02 63.81 LARYNGEAL CANCER | 1 0.01 63.82 LARYNGITIS | 1 0.01 63.83 LEFT VENTRICULAR DYSFUNCTION | 2 0.02 63.85 LEFT VENTRICULAR FAILURE | 2 0.02 63.87 LEIOMYOSARCOMA | 1 0.01 63.88 LEIOMYOSARCOMA RECURRENT | 3 0.03 63.91 LEUKAEMIA | 2 0.02 63.93 LEUKOCYTOSIS | 2 0.02 63.95 LICE INFESTATION | 1 0.01 63.96 LIPID METABOLISM DISORDER | 1 0.01 63.97 LIPIDS | 2 0.02 63.99 LIPIDS INCREASED | 4 0.04 64.03 LIVER DISORDER | 4 0.04 64.07 LIVER TRANSPLANT | 7 0.07 64.14 LOCAL ANAESTHESIA | 1 0.01 64.15 LOCALISED INFECTION | 2 0.02 64.17 LONG QT SYNDROME | 1 0.01 64.18 LOW DENSITY LIPOPROTEIN | 1 0.01 64.19 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 64.20 LOWER RESPIRATORY TRACT INFECTION | 2 0.02 64.22 LOWER RESPIRATORY TRACT INFECTION BAC.. | 1 0.01 64.23 LOWER RESPIRATORY TRACT INFLAMMATION | 1 0.01 64.24 LUMBAR RADICULOPATHY | 1 0.01 64.25 LUMBAR SPINAL STENOSIS | 3 0.03 64.28 LUNG ADENOCARCINOMA | 6 0.06 64.34 LUNG ADENOCARCINOMA STAGE III | 1 0.01 64.35 LUNG ADENOCARCINOMA STAGE IV | 1 0.01 64.36 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 64.37 LUNG CONSOLIDATION | 1 0.01 64.38 LUNG DISORDER | 12 0.12 64.50 LUNG INFECTION | 4 0.04 64.54 LUNG NEOPLASM | 1 0.01 64.55 LUNG NEOPLASM MALIGNANT | 6 0.06 64.61 LUPUS NEPHRITIS | 4 0.04 64.65 LYMPHOCYTIC LEUKAEMIA | 1 0.01 64.66 LYMPHOMA | 9 0.09 64.75 MACULAR DEGENERATION | 20 0.20 64.95 MAINTENANCE OF ANAESTHESIA | 3 0.03 64.98 MAJOR DEPRESSION | 22 0.22 65.20 MALARIA | 1 0.01 65.21 MALIGNANT LYMPHOID NEOPLASM | 1 0.01 65.22 MALIGNANT MELANOMA | 2 0.02 65.24 MALIGNANT SOFT TISSUE NEOPLASM | 1 0.01 65.25 MALNUTRITION | 1 0.01 65.26 MANIA | 6 0.06 65.32 MANTLE CELL LYMPHOMA | 1 0.01 65.33 MASS | 1 0.01 65.34 MATERNAL DRUGS AFFECTING FOETUS | 1 0.01 65.35 MATERNAL THERAPY TO ENHANCE FOETAL LU.. | 2 0.02 65.37 MEDICAL DIET | 13 0.13 65.50 MEMORY IMPAIRMENT | 1 0.01 65.51 MENIERE'S DISEASE | 2 0.02 65.53 MENINGIOMA | 4 0.04 65.57 MENINGITIS | 2 0.02 65.59 MENINGOCOCCAL SEPSIS | 3 0.03 65.62 MENOPAUSE | 17 0.17 65.79 MENORRHAGIA | 3 0.03 65.82 MENSTRUAL CYCLE MANAGEMENT | 1 0.01 65.83 MENSTRUAL DISORDER | 1 0.01 65.84 MENSTRUATION IRREGULAR | 1 0.01 65.85 MENTAL DISORDER | 6 0.06 65.91 METABOLIC DISORDER | 1 0.01 65.92 METASTASES TO ADRENALS | 1 0.01 65.93 METASTASES TO BONE | 42 0.42 66.35 METASTASES TO LARGE INTESTINE | 1 0.01 66.36 METASTATIC CARCINOID TUMOUR | 1 0.01 66.37 METASTATIC GASTRIC CANCER | 3 0.03 66.40 METASTATIC NEOPLASM | 1 0.01 66.41 METASTATIC RENAL CELL CARCINOMA | 33 0.33 66.74 METRORRHAGIA | 1 0.01 66.75 MICTURITION DISORDER | 1 0.01 66.76 MICTURITION URGENCY | 2 0.02 66.78 MIGRAINE | 17 0.17 66.95 MIGRAINE PROPHYLAXIS | 4 0.04 66.99 MINERAL SUPPLEMENTATION | 1 0.01 67.00 MITRAL VALVE REPLACEMENT | 1 0.01 67.01 MOBILITY DECREASED | 1 0.01 67.02 MOOD ALTERED | 2 0.02 67.04 MOOD SWINGS | 3 0.03 67.07 MORTON'S NEUROMA | 1 0.01 67.08 MOTION SICKNESS | 1 0.01 67.09 MUCOPOLYSACCHARIDOSIS II | 1 0.01 67.10 MUCOSAL INFLAMMATION | 1 0.01 67.11 MULTI-ORGAN FAILURE | 2 0.02 67.13 MULTIPLE ALLERGIES | 15 0.15 67.28 MULTIPLE MYELOMA | 135 1.35 68.63 MULTIPLE SCLEROSIS | 193 1.93 70.56 MUSCLE RELAXANT THERAPY | 3 0.03 70.59 MUSCLE SPASMS | 16 0.16 70.75 MUSCLE SPASTICITY | 4 0.04 70.79 MUSCULOSKELETAL DISCOMFORT | 1 0.01 70.80 MUSCULOSKELETAL PAIN | 13 0.13 70.93 MUSCULOSKELETAL STIFFNESS | 2 0.02 70.95 MYALGIA | 4 0.04 70.99 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 1 0.01 71.00 MYCOPLASMA INFECTION | 1 0.01 71.01 MYCOSIS FUNGOIDES | 3 0.03 71.04 MYCOTIC ALLERGY | 1 0.01 71.05 MYELODYSPLASTIC SYNDROME | 14 0.14 71.19 MYELOFIBROSIS | 4 0.04 71.23 MYOCARDIAL INFARCTION | 18 0.18 71.41 MYOCARDIAL ISCHAEMIA | 2 0.02 71.43 MYOSITIS | 2 0.02 71.45 NARCOLEPSY | 2 0.02 71.47 NASAL CONGESTION | 5 0.05 71.52 NASOPHARYNGITIS | 29 0.29 71.81 NAUSEA | 45 0.45 72.26 NECK INJURY | 1 0.01 72.27 NECK PAIN | 5 0.05 72.32 NEOPLASM | 4 0.04 72.36 NEOPLASM MALIGNANT | 14 0.14 72.50 NEPHROGENIC ANAEMIA | 2 0.02 72.52 NERVE INJURY | 2 0.02 72.54 NERVOUS SYSTEM DISORDER | 2 0.02 72.56 NERVOUSNESS | 2 0.02 72.58 NEURALGIA | 21 0.21 72.79 NEUROECTODERMAL NEOPLASM | 1 0.01 72.80 NEUROENDOCRINE CARCINOMA | 4 0.04 72.84 NEUROENDOCRINE TUMOUR | 3 0.03 72.87 NEUROPATHY PERIPHERAL | 13 0.13 73.00 NEUROPSYCHIATRIC LUPUS | 1 0.01 73.01 NEUTROPENIA | 3 0.03 73.04 NEUTROPENIC SEPSIS | 5 0.05 73.09 NICOTINE DEPENDENCE | 1 0.01 73.10 NON-HODGKIN'S LYMPHOMA | 23 0.23 73.33 NON-SMALL CELL LUNG CANCER | 76 0.76 74.09 NON-SMALL CELL LUNG CANCER STAGE IIIB | 2 0.02 74.11 NON-SMALL CELL LUNG CANCER STAGE IV | 9 0.09 74.20 NUCLEAR MAGNETIC RESONANCE IMAGING | 51 0.51 74.71 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 3 0.03 74.74 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 13 0.13 74.87 NUCLEAR MAGNETIC RESONANCE IMAGING TH.. | 1 0.01 74.88 NUTRITIONAL SUPPORT | 5 0.05 74.93 OBESITY | 2 0.02 74.95 OBSESSIVE-COMPULSIVE DISORDER | 9 0.09 75.04 OBSTRUCTION | 1 0.01 75.05 OCULAR HYPERAEMIA | 1 0.01 75.06 ODYNOPHAGIA | 3 0.03 75.09 OEDEMA | 2 0.02 75.11 OEDEMA PERIPHERAL | 2 0.02 75.13 OESOPHAGEAL CANDIDIASIS | 1 0.01 75.14 OESOPHAGEAL CARCINOMA | 8 0.08 75.22 OESTROGEN REPLACEMENT THERAPY | 1 0.01 75.23 OFF LABEL USE | 1 0.01 75.24 ONYCHOMYCOSIS | 8 0.08 75.32 OPPOSITIONAL DEFIANT DISORDER | 1 0.01 75.33 OPTIC NERVE DISORDER | 1 0.01 75.34 ORAL CANDIDIASIS | 1 0.01 75.35 ORAL FUNGAL INFECTION | 3 0.03 75.38 ORAL HERPES | 2 0.02 75.40 OROPHARYNGEAL CANDIDIASIS | 2 0.02 75.42 OROPHARYNGEAL DISCOMFORT | 2 0.02 75.44 OROPHARYNGEAL PAIN | 2 0.02 75.46 ORTHOSTATIC HYPOTENSION | 2 0.02 75.48 OSTEITIS DEFORMANS | 1 0.01 75.49 OSTEOARTHRITIS | 7 0.07 75.56 OSTEOCHONDROSIS | 1 0.01 75.57 OSTEOLYSIS | 1 0.01 75.58 OSTEOMYELITIS | 4 0.04 75.62 OSTEOPENIA | 9 0.09 75.71 OSTEOPOROSIS | 166 1.66 77.37 OSTEOPOROSIS POSTMENOPAUSAL | 8 0.08 77.45 OSTEOPOROSIS PROPHYLAXIS | 7 0.07 77.52 OSTEOPOROTIC FRACTURE | 1 0.01 77.53 OTITIS EXTERNA | 1 0.01 77.54 OTITIS MEDIA | 1 0.01 77.55 OTITIS MEDIA ACUTE | 1 0.01 77.56 OVARIAN CANCER | 13 0.13 77.69 OVARIAN CANCER RECURRENT | 2 0.02 77.71 OVARIAN CYST | 1 0.01 77.72 OVARIAN DISORDER | 1 0.01 77.73 OVERDOSE | 1 0.01 77.74 OVERWEIGHT | 1 0.01 77.75 OXYGEN SATURATION DECREASED | 1 0.01 77.76 PAIN | 161 1.61 79.37 PAIN IN EXTREMITY | 13 0.13 79.50 PAIN MANAGEMENT | 5 0.05 79.55 PALLIATIVE CARE | 1 0.01 79.56 PANCREAS TRANSPLANT | 3 0.03 79.59 PANCREATIC CARCINOMA | 6 0.06 79.65 PANCREATIC CARCINOMA NON-RESECTABLE | 2 0.02 79.67 PANCREATIC CARCINOMA STAGE IV | 1 0.01 79.68 PANCREATIC NEUROENDOCRINE TUMOUR | 4 0.04 79.72 PANCREATITIS | 1 0.01 79.73 PANCREATITIS CHRONIC | 1 0.01 79.74 PANIC ATTACK | 7 0.07 79.81 PANIC DISORDER | 4 0.04 79.85 PARALYSIS | 2 0.02 79.87 PARKINSON'S DISEASE | 21 0.21 80.08 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 11 0.11 80.19 PARTIAL SEIZURES | 4 0.04 80.23 PATERNAL DRUGS AFFECTING FOETUS | 1 0.01 80.24 PELVIC FRACTURE | 1 0.01 80.25 PENIS DISORDER | 1 0.01 80.26 PEPTIC ULCER | 3 0.03 80.29 PERFORATED ULCER | 2 0.02 80.31 PERIODONTAL DISEASE | 2 0.02 80.33 PERIPHERAL SENSORY NEUROPATHY | 3 0.03 80.36 PERIPHERAL VASCULAR DISORDER | 1 0.01 80.37 PERITONEAL DIALYSIS | 91 0.91 81.28 PERITONITIS | 2 0.02 81.30 PERSONALITY DISORDER | 2 0.02 81.32 PHARYNGEAL DISORDER | 1 0.01 81.33 PHARYNGITIS | 3 0.03 81.36 PHARYNGITIS BACTERIAL | 1 0.01 81.37 PHLEBITIS | 2 0.02 81.39 PHOBIA OF FLYING | 1 0.01 81.40 PHOTOPHOBIA | 1 0.01 81.41 PITUITARY TUMOUR BENIGN | 1 0.01 81.42 PLEURAL MESOTHELIOMA MALIGNANT | 2 0.02 81.44 PLEURISY | 1 0.01 81.45 PNEUMOCOCCAL SEPSIS | 1 0.01 81.46 PNEUMOCYSTIS JIROVECI PNEUMONIA | 1 0.01 81.47 PNEUMONECTOMY | 1 0.01 81.48 PNEUMONIA | 20 0.20 81.68 PNEUMONIA ASPIRATION | 2 0.02 81.70 PNEUMONIA BACTERIAL | 6 0.06 81.76 PNEUMOPERITONEUM | 2 0.02 81.78 POLLAKIURIA | 3 0.03 81.81 POLYARTHRITIS | 1 0.01 81.82 POLYMYALGIA RHEUMATICA | 2 0.02 81.84 POLYMYOSITIS | 2 0.02 81.86 POLYNEUROPATHY | 5 0.05 81.91 POOR PERIPHERAL CIRCULATION | 1 0.01 81.92 POOR QUALITY SLEEP | 1 0.01 81.93 POST HERPETIC NEURALGIA | 1 0.01 81.94 POST-TRAUMATIC STRESS DISORDER | 4 0.04 81.98 POSTINFARCTION ANGINA | 2 0.02 82.00 POSTOPERATIVE ANALGESIA | 6 0.06 82.06 POSTPARTUM DEPRESSION | 2 0.02 82.08 POSTURAL ORTHOSTATIC TACHYCARDIA SYND.. | 1 0.01 82.09 POUCHITIS | 1 0.01 82.10 PRADER-WILLI SYNDROME | 1 0.01 82.11 PRECURSOR T-LYMPHOBLASTIC LYMPHOMA/LE.. | 2 0.02 82.13 PREGNANCY | 1 0.01 82.14 PREMATURE LABOUR | 1 0.01 82.15 PREMEDICATION | 58 0.58 82.73 PREMENSTRUAL SYNDROME | 2 0.02 82.75 PREOPERATIVE CARE | 1 0.01 82.76 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS | 1 0.01 82.77 PROCEDURAL HYPOTENSION | 2 0.02 82.79 PROCEDURAL PAIN | 2 0.02 82.81 PROCTALGIA | 1 0.01 82.82 PROCTOCOLECTOMY | 1 0.01 82.83 PROPHYLAXIS | 149 1.49 84.32 PROPHYLAXIS AGAINST DEHYDRATION | 1 0.01 84.33 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 10 0.10 84.43 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 5 0.05 84.48 PROPHYLAXIS AGAINST HIV INFECTION | 3 0.03 84.51 PROPHYLAXIS AGAINST MOTION SICKNESS | 1 0.01 84.52 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 11 0.11 84.63 PROPHYLAXIS OF NAUSEA AND VOMITING | 10 0.10 84.73 PROPHYLAXIS URINARY TRACT INFECTION | 2 0.02 84.75 PROSTATE CANCER | 35 0.35 85.10 PROSTATE CANCER METASTATIC | 3 0.03 85.13 PROSTATE CANCER STAGE III | 2 0.02 85.15 PROSTATE CANCER STAGE IV | 4 0.04 85.19 PROSTATIC DISORDER | 3 0.03 85.22 PROSTATIC OBSTRUCTION | 1 0.01 85.23 PROSTATITIS | 1 0.01 85.24 PROSTATOMEGALY | 14 0.14 85.38 PRURITUS | 10 0.10 85.48 PSEUDOMONAS INFECTION | 2 0.02 85.50 PSORIASIS | 31 0.31 85.81 PSORIATIC ARTHROPATHY | 32 0.32 86.13 PSYCHOMOTOR HYPERACTIVITY | 1 0.01 86.14 PSYCHOMOTOR SEIZURES | 1 0.01 86.15 PSYCHOTIC DISORDER | 10 0.10 86.25 PULMONARY ARTERIAL HYPERTENSION | 23 0.23 86.48 PULMONARY CONGESTION | 1 0.01 86.49 PULMONARY EMBOLISM | 15 0.15 86.64 PULMONARY HYPERTENSION | 15 0.15 86.79 PULMONARY OEDEMA | 1 0.01 86.80 PUSTULAR PSORIASIS | 1 0.01 86.81 PYELONEPHRITIS | 6 0.06 86.87 PYODERMA GANGRENOSUM | 1 0.01 86.88 PYREXIA | 40 0.40 87.28 RASH | 13 0.13 87.41 RECTAL CANCER | 13 0.13 87.54 RECTAL CANCER METASTATIC | 4 0.04 87.58 RECTAL HAEMORRHAGE | 1 0.01 87.59 RED BLOOD CELL COUNT INCREASED | 1 0.01 87.60 REFLUX GASTRITIS | 1 0.01 87.61 REFLUX OESOPHAGITIS | 5 0.05 87.66 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 12 0.12 87.78 RELAXATION THERAPY | 2 0.02 87.80 RENAL CANCER | 7 0.07 87.87 RENAL CANCER METASTATIC | 4 0.04 87.91 RENAL CELL CARCINOMA | 56 0.56 88.47 RENAL CELL CARCINOMA STAGE IV | 2 0.02 88.49 RENAL FAILURE | 1 0.01 88.50 RENAL FAILURE ACUTE | 1 0.01 88.51 RENAL FAILURE CHRONIC | 18 0.18 88.69 RENAL IMPAIRMENT | 1 0.01 88.70 RENAL TRANSPLANT | 45 0.45 89.15 RESPIRATORY DEPRESSION | 1 0.01 89.16 RESPIRATORY TRACT CONGESTION | 1 0.01 89.17 RESPIRATORY TRACT INFECTION | 7 0.07 89.24 RESPIRATORY TRACT IRRITATION | 2 0.02 89.26 RESTLESS LEGS SYNDROME | 9 0.09 89.35 RESTLESSNESS | 2 0.02 89.37 RETINAL HAEMORRHAGE | 1 0.01 89.38 RETROPERITONEAL FIBROSIS | 2 0.02 89.40 RHABDOMYOSARCOMA | 72 0.72 90.12 RHEUMATOID ARTHRITIS | 276 2.76 92.88 RHINITIS | 3 0.03 92.91 RHINITIS ALLERGIC | 6 0.06 92.97 RHINITIS PERENNIAL | 1 0.01 92.98 RHINORRHOEA | 2 0.02 93.00 ROUTINE HEALTH MAINTENANCE | 1 0.01 93.01 SARCOMA | 5 0.05 93.06 SCAN WITH CONTRAST | 2 0.02 93.08 SCHIZOAFFECTIVE DISORDER | 13 0.13 93.21 SCHIZOPHRENIA | 82 0.82 94.03 SCHIZOPHRENIA, PARANOID TYPE | 4 0.04 94.07 SCIATICA | 4 0.04 94.11 SCIMITAR SYNDROME | 2 0.02 94.13 SEASONAL ALLERGY | 3 0.03 94.16 SEDATION | 10 0.10 94.26 SEDATIVE THERAPY | 3 0.03 94.29 SELECTIVE IGA IMMUNODEFICIENCY | 2 0.02 94.31 SENILE DEMENTIA | 2 0.02 94.33 SEPSIS | 7 0.07 94.40 SEPTIC SHOCK | 2 0.02 94.42 SERUM FERRITIN INCREASED | 3 0.03 94.45 SHORT-BOWEL SYNDROME | 2 0.02 94.47 SICKLE CELL ANAEMIA | 8 0.08 94.55 SIGMOIDECTOMY | 1 0.01 94.56 SINUS DISORDER | 5 0.05 94.61 SINUS HEADACHE | 1 0.01 94.62 SINUS POLYP | 1 0.01 94.63 SINUSITIS | 16 0.16 94.79 SJOGREN'S SYNDROME | 4 0.04 94.83 SKIN INFECTION | 1 0.01 94.84 SKIN LESION | 1 0.01 94.85 SKIN WRINKLING | 1 0.01 94.86 SLEEP DISORDER | 38 0.38 95.24 SLEEP DISORDER THERAPY | 1 0.01 95.25 SMALL CELL CARCINOMA | 1 0.01 95.26 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 4 0.04 95.30 SMOKING CESSATION THERAPY | 43 0.43 95.73 SNEEZING | 1 0.01 95.74 SOFT TISSUE DISORDER | 3 0.03 95.77 SOMNOLENCE | 3 0.03 95.80 SPINAL ANAESTHESIA | 1 0.01 95.81 SPINAL COLUMN STENOSIS | 4 0.04 95.85 SPINAL FRACTURE | 1 0.01 95.86 SPINAL FUSION SURGERY | 1 0.01 95.87 SPINAL LAMINECTOMY | 1 0.01 95.88 SPLENOMEGALY | 1 0.01 95.89 SPONDYLITIS | 1 0.01 95.90 SQUAMOUS CELL CARCINOMA | 1 0.01 95.91 STAPHYLOCOCCAL ABSCESS | 2 0.02 95.93 STAPHYLOCOCCAL INFECTION | 6 0.06 95.99 STATUS EPILEPTICUS | 2 0.02 96.01 STENT PLACEMENT | 2 0.02 96.03 STOMATITIS | 2 0.02 96.05 SUICIDAL BEHAVIOUR | 1 0.01 96.06 SUICIDE ATTEMPT | 2 0.02 96.08 SUPPLEMENTATION THERAPY | 5 0.05 96.13 SUPPORTIVE CARE | 1 0.01 96.14 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.15 SURGERY | 9 0.09 96.24 SYSTEMIC LUPUS ERYTHEMATOSUS | 6 0.06 96.30 T-CELL LYMPHOMA STAGE IV | 1 0.01 96.31 TACHYARRHYTHMIA | 4 0.04 96.35 TACHYCARDIA | 2 0.02 96.37 TEETHING | 1 0.01 96.38 TENDONITIS | 3 0.03 96.41 TENSION | 7 0.07 96.48 THALASSAEMIA | 2 0.02 96.50 THALASSAEMIA BETA | 1 0.01 96.51 THERAPEUTIC PROCEDURE | 1 0.01 96.52 THROMBOCYTOPENIA | 2 0.02 96.54 THROMBOSIS | 2 0.02 96.56 THROMBOSIS PROPHYLAXIS | 37 0.37 96.93 THYROID CANCER | 2 0.02 96.95 THYROID DISORDER | 14 0.14 97.09 THYROID OPERATION | 1 0.01 97.10 THYROIDECTOMY | 1 0.01 97.11 TINEA PEDIS | 2 0.02 97.13 TOBACCO ABUSE | 2 0.02 97.15 TOBACCO USER | 4 0.04 97.19 TOCOLYSIS | 2 0.02 97.21 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 97.22 TOOTH ABSCESS | 1 0.01 97.23 TOOTH INFECTION | 1 0.01 97.24 TOOTHACHE | 3 0.03 97.27 TOURETTE'S DISORDER | 5 0.05 97.32 TOXOPLASMOSIS | 6 0.06 97.38 TRACHEITIS | 2 0.02 97.40 TRANSFUSION | 1 0.01 97.41 TRANSIENT ISCHAEMIC ATTACK | 3 0.03 97.44 TRANSITIONAL CELL CARCINOMA | 2 0.02 97.46 TRANSPLANT | 3 0.03 97.49 TRANSPLANT FAILURE | 1 0.01 97.50 TREMOR | 2 0.02 97.52 TRIGEMINAL NEURALGIA | 6 0.06 97.58 TUBERCULIN TEST | 1 0.01 97.59 TUBERCULOSIS | 3 0.03 97.62 TUMOUR ASSOCIATED FEVER | 3 0.03 97.65 TUMOUR PAIN | 5 0.05 97.70 TYPE 1 DIABETES MELLITUS | 18 0.18 97.88 TYPE 2 DIABETES MELLITUS | 90 0.90 98.78 TYPE V HYPERLIPIDAEMIA | 1 0.01 98.79 ULCER | 2 0.02 98.81 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 98.82 UPPER RESPIRATORY TRACT INFECTION | 3 0.03 98.85 URETHRAL CANCER | 5 0.05 98.90 URINARY BLADDER EXCISION | 1 0.01 98.91 URINARY INCONTINENCE | 2 0.02 98.93 URINARY RETENTION | 3 0.03 98.96 URINARY TRACT DISORDER | 4 0.04 99.00 URINARY TRACT INFECTION | 24 0.24 99.24 URINARY TRACT INFECTION BACTERIAL | 1 0.01 99.25 URINARY TRACT INFECTION STAPHYLOCOCCAL | 2 0.02 99.27 URINE CALCIUM | 1 0.01 99.28 URTICARIA | 2 0.02 99.30 VAGINAL HAEMORRHAGE | 2 0.02 99.32 VARICOSE VEIN | 1 0.01 99.33 VASCULAR DEMENTIA | 1 0.01 99.34 VASCULAR TEST | 1 0.01 99.35 VASCULITIS | 5 0.05 99.40 VASECTOMY | 1 0.01 99.41 VASOCONSTRICTION | 1 0.01 99.42 VENTRICULAR EXTRASYSTOLES | 2 0.02 99.44 VENTRICULAR TACHYCARDIA | 4 0.04 99.48 VERTIGO | 2 0.02 99.50 VERTIGO POSITIONAL | 1 0.01 99.51 VIRAEMIA | 2 0.02 99.53 VIRAL INFECTION | 3 0.03 99.56 VITAMIN B COMPLEX DEFICIENCY | 1 0.01 99.57 VITAMIN B12 DEFICIENCY | 1 0.01 99.58 VITAMIN D DEFICIENCY | 2 0.02 99.60 VITAMIN K DEFICIENCY | 1 0.01 99.61 VITAMIN SUPPLEMENTATION | 16 0.16 99.77 VOMITING | 15 0.15 99.92 VULVOVAGINAL PAIN | 1 0.01 99.93 WEGENER'S GRANULOMATOSIS | 1 0.01 99.94 WEIGHT CONTROL | 2 0.02 99.96 WEIGHT INCREASED | 1 0.01 99.97 WEIGHT LOSS DIET | 1 0.01 99.98 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.99 WOUND INFECTION | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015